SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-000895
Filing Date
2021-02-11
Accepted
2021-02-11 07:02:33
Documents
64
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20201231x10q.htm   iXBRL 10-Q 1308541
2 EX-31.1 tmb-20201231xex31d1.htm EX-31.1 7129
3 EX-31.2 tmb-20201231xex31d2.htm EX-31.2 7119
4 EX-32.1 tmb-20201231xex32d1.htm EX-32.1 9213
5 GRAPHIC tmb-20201231x10q001.jpg GRAPHIC 18164
  Complete submission text file 0001558370-21-000895.txt   5104660

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20201231.xsd EX-101.SCH 43751
7 EX-101.CAL tmb-20201231_cal.xml EX-101.CAL 33524
8 EX-101.DEF tmb-20201231_def.xml EX-101.DEF 126596
9 EX-101.LAB tmb-20201231_lab.xml EX-101.LAB 348453
10 EX-101.PRE tmb-20201231_pre.xml EX-101.PRE 260795
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20201231x10q_htm.xml XML 804564
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37410 | Film No.: 21616641
SIC: 2834 Pharmaceutical Preparations